Hualan Biological Engineering
002007.SZ
#2980
Rank
โ‚น348.18 B
Marketcap
โ‚น190.39
Share price
-0.67%
Change (1 day)
-13.47%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Revenue for Hualan Biological Engineering (002007.SZ)

Revenue in 2024 (TTM): โ‚น51.41 Billion

According to Hualan Biological Engineering's latest financial reports the company's current revenue (TTM ) is โ‚น52.22 Billion. a decrease over the revenue in the year 2023 that were of โ‚น62.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Hualan Biological Engineering from 2004 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น52.50 B-16.17%
2023 โ‚น62.63 B13.92%
2022 โ‚น54.98 B7.56%
2021 โ‚น51.12 B-5.8%
2020 โ‚น54.26 B43.02%
2019 โ‚น37.94 B13.24%
2018 โ‚น33.50 B48.2%
2017 โ‚น22.61 B14.96%
2016 โ‚น19.66 B26.96%
2015 โ‚น15.49 B21.47%
2014 โ‚น12.75 B13.17%
2013 โ‚น11.27 B33.01%
2012 โ‚น8.47 B7.01%
2011 โ‚น7.91 B-5.87%
2010 โ‚น8.41 B1.41%
2009 โ‚น8.29 B149.09%
2008 โ‚น3.33 B81.83%
2007 โ‚น1.83 B-7.29%
2006 โ‚น1.97 B-0.78%
2005 โ‚น1.99 B18.49%
2004 โ‚น1.68 B